{
    "2018-05-31": [
        [
            {
                "time": "2018-04-25",
                "original_text": "How Novartis’s Business Segments Did in Q1",
                "features": {
                    "keywords": [
                        "Novartis",
                        "business segments",
                        "Q1"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-30",
                "original_text": "Assessing GlaxoSmithKline’s Quarterly Revenues",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "quarterly revenues"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Pfizer's Arthritis Drug Gets FDA Nod for Ulcerative Colitis",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "arthritis drug",
                        "FDA",
                        "ulcerative colitis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-05",
                "original_text": "Top Diabetes Stocks to Buy Today",
                "features": {
                    "keywords": [
                        "diabetes stocks",
                        "buy today"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "How Is JNJ Maintaining Its Momentum in Interventional Solutions?",
                "features": {
                    "keywords": [
                        "JNJ",
                        "momentum",
                        "interventional solutions"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "Johnson & Johnson and the Baby Powder Litigations",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "baby powder",
                        "litigations"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "How JNJ Is Recreating Its Commercial Model for Medical Devices",
                "features": {
                    "keywords": [
                        "JNJ",
                        "commercial model",
                        "medical devices"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-25",
                "original_text": "Amgen Focused on Advancing Oncology Research Programs in 2018",
                "features": {
                    "keywords": [
                        "Amgen",
                        "oncology research",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-01",
                "original_text": "Johnson & Johnson Responds to Meet Consumer Needs Faster",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "consumer needs",
                        "faster"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Sage’s Brexanolone IV: FDA Grants Priority Review",
                "features": {
                    "keywords": [
                        "Sage",
                        "Brexanolone IV",
                        "FDA",
                        "priority review"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-10",
                "original_text": "Discussing the Shift in Johnson & Johnson’s Research Strategy",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "research strategy",
                        "shift"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Johnson & Johnson’s Growth Strategy: Expand Emerging Channels",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "growth strategy",
                        "emerging channels"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-20",
                "original_text": "7 Inflation-Beating Stocks to Consider for This New Reality",
                "features": {
                    "keywords": [
                        "inflation-beating stocks",
                        "new reality"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}